The role of GCN2 in other cancers has also been investigated; for example, tumor xenograft studies of head and neck squamous cell carcinoma (HNSCC), or fibrosarcoma (HT1080) cell lines with GCN2 deletions prevented tumor growth and survival [17,24]. The gene discussed is EIF2AK4; the disease is fibrosarcoma.